Related Experiment Video
Updated: Mar 19, 2026
05:16
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
750
Hemoglobin Kinetics and Long-term Prognosis in Heart Failure
Carles Díez-López1, Josep Lupón2, Marta de Antonio1
1Unitat d'Insuficiència Cardíaca, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
Revista Espanola De Cardiologia (English Ed.)
|June 20, 2016
Summary
Anemia negatively impacts heart failure outcomes. Persistent and new-onset anemia significantly increase mortality risk, while transient anemia also shows a concerning trend.
Area of Science:
- Cardiology
- Hematology
Background:
- The prognostic impact of hemoglobin kinetics in heart failure patients remains unclear.
- Understanding anemia's role is crucial for improving heart failure management.
Purpose of the Study:
- To investigate the association between hemoglobin levels, anemia classification, and mortality in patients with heart failure.
- To determine if different patterns of anemia (persistent, transient, new-onset) have varying effects on heart failure outcomes.
Main Methods:
- Hemoglobin levels were measured at baseline and 6 months in 1173 heart failure patients.
- Patients were categorized into nonanemic, transiently anemic, newly anemic, or permanently anemic groups based on WHO criteria.
- Outcomes, including all-cause mortality, were assessed over a mean follow-up of 3.7 years.
Main Results:
- Anemia was prevalent, with 32.4% of patients having persistent anemia and 12.5% developing new-onset anemia.
- Both persistent anemia (HR=1.62) and new-onset anemia (HR=1.39) were independent predictors of increased all-cause mortality.
- Transient anemia also suggested a trend towards higher mortality (HR=1.31), though not statistically significant.
Conclusions:
- Anemia is a significant negative prognostic factor in heart failure.
- Persistent and new-onset anemia are particularly detrimental, highlighting the need for monitoring and intervention.
- Even transient anemia may warrant clinical attention in heart failure management.
More Related Videos
09:47Author Spotlight: Utilizing Next-Generation Polymerized Human Hemoglobin for Improved Donor Lung Evaluation and Preservation in Rats
Published on: June 14, 2024
1.3K
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
6.3K
Related Concept Videos
01:17Pathophysiology of Heart Failure
4.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
01:29Heart Failure II: Pathophysiology
1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
01:30Heart Failure VII: Nursing Interventions
659
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
659
01:30Heart Failure V: Medical Management
478
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
478
01:22Heart Failure VI: Adjunct Therapies
511
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
511
01:27Heart Failure I: Introduction
1.2K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K